Company chart and information is provided by TradingView based on 15-minute-delayed data.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. It is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release & immediate-release formulations of tapentadol.
Website: | www.collegiumpharma.com |
Email: | info@collegiumpharma.com |
Main Phone: | +1 781 713-3699 |
Address: | 100 Technology Center Drive |
Address 2: | Suite 800 |
State: | MA |
City / Town: | Stoughton |
Country: | US |
Postal Code: | 02072 |
Exchange: | NGS |
CEO: | Joseph J. Ciaffoni |
Employees: | 234 |
NAICS: | Pharmaceutical Preparation Manufacturing(325412) |
Last Price N/A | Change $ N/A | Change % N/A | Tick N/A |
Bid N/A | Bid Size N/A | Ask N/A | Ask Size N/A |
Open N/A | High N/A | Low N/A | Prev Close N/A |
Last Trade | Volume N/A | 52 Wk Hi N/A | 52 Wk Low N/A |
Market Cap N/A | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
Shares N/A | EPS (TTM) N/A | PE Ratio N/A | Exchange N/A |